Correspondence  by unknown
only finding in relation to diastolic RV physiology and should not be
seen in isolation. We strongly believe there is a need to address
possible relations between age at repair and other contributing factors
to subsequent diastolic physiology in larger studies. Unfortunately, so
far, the interest for studies of early repair and diastolic RV function
have been lacking from several large centers.
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REPLY
We appreciate the interest expressed by someone as experienced in
the field of heart diseases and pregnancy as Dr. Oakley (J Am Coll
Cardiol 1999;33:287) concerning our analysis of pulmonary vas-
cular disease (PVD) in pregnant women (1).
We recognized well in advance and clearly stated the limitations of
our analysis of PVD in pregnancy (1). There is plenty of room for
disagreement, because local experiences, successes and failures with
pregnant women who have PVD may differ widely. It is left to the
readers to extrapolate the findings of our study in accordance with
their own institutional practice. The statistical analysis showed that
cesarean section was a significant risk factor in secondary pulmonary
vascular hypertension, but not in the group of patients with Eisen-
menger’s syndrome. When cases of Eisenmenger’s syndrome and
primary and secondary pulmonary vascular hypertension were pooled
together, operative delivery emerged as a strong risk in the univariate
analysis, but as a weaker one in the multivariate analysis (1). We cited
the editorial of Dr. Oakley, who wrote “. . . fetal growth will eventu-
ally fail and the fetus has to be delivered. The safest route is by
cesarean section under general anaesthesia with generous hydration,
avoidance of systemic vasodilation agents, and prompt replacement of
blood loss” (2). With regard to cyanosis in women with low pulmo-
nary pressure, again a position in favor of cesarean section is taken by
Dr. Oakley (2). Thus, the citation, as stated in the editorial, did not
misrepresent the author’s views. Our conclusion was that cesarean
section should be considered a risk (co)factor in parturients with
PVD, and the editorial was cited to express the difference with
Oakley’s opinion on the “safest” route for delivery (1,2).
The link(s) between a single aspect of management and out-
come, except for the late diagnosis and late hospital admission (1),
are missing and nothing seems to be “safe” in pregnant women
with PVD. Of course, it is possible that patients delivered
operatively may have represented more severe cases (less so for
cyanosis but more so for severity of PVD), or that an individual
patient would be much better managed by some other techniques
or strategies than those actually used. The retrospective overview
showed that timing and mode of delivery could not differentiate
between maternal survival and death in Eisenmenger’s syndrome
(1). We agree that conclusions drawn from an overview of the
published data can be misleading. False conclusions may be drawn
from case reports, prospective randomized studies or editorials. If
we made the same mistake as made by Gleicher et al. (3) in their
classic paper on Eisenmenger’s syndrome and pregnancy in
1979, so be it, we take it as a compliment. Dr. Oakley ends by
questioning our personal experiences in these matters. Clinical
experiences are never visible in the quotations.
In the meantime, as has been the case over the past 50 years (1,3),
pregnant women with Eisenmenger’s syndrome continue to survive or
die independently of vaginal or operative delivery, general or regional
anesthesia and, unfortunately, despite the availability of new pulmo-
nary vasodilators (4–9). At the maternal mortality rate of 30% to 50%,
the “safest” route of management of pregnant women with Eisen-
menger’s syndrome still remains to be defined.
[Dr. Weiss’s reply to Dr. Oakley was received February 26,
1999. We regret the delay in publishing this reply.]
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